Hide Studies Not Open or Pending
Condition(s):Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc AlterationsLast Updated:September 3, 2019Completed
Condition(s):Relapsed Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell LymphomaLast Updated:November 10, 2020Completed
Condition(s):Chidamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasm by Histology; Neoplasms; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases; Lymphoma, Non-Hodgkin; Cyclophosphamide; Rituximab; Gemcitabine; Cisplatin; Dexamethasone; HDAC InhibitorLast Updated:December 14, 2017Unknown status
Condition(s):Recurrent Adult Diffuse Large Cell LymphomaLast Updated:February 3, 2016Terminated
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:February 24, 2021Active, not recruiting
Condition(s):Relapsed, Diffuse Large B-cell Lymphoma; Refractory Diffuse Large B-Cell LymphomaLast Updated:December 1, 2020Recruiting
Condition(s):Diffuse Large B-cell LymphomaLast Updated:March 16, 2016Withdrawn
Condition(s):Non-Hodgkin’s Lymphoma; Lymphoma, Large Cell; Diffuse, Mantle Cell Lymphoma, Lymphoma; Follicular Lymphoma; Large B-Cell, DiffuseLast Updated:July 4, 2013Completed
Condition(s):Diffuse, Large B-Cell, LymphomaLast Updated:January 4, 2019Completed
Condition(s):Diffuse Large B-cell Lymphoma (DLBCL); Relapsed Diffuse Large B-cell Lymphoma (DLBCL); Refractory Diffuse Large B-cell Lymphoma (DLBCL)Last Updated:June 25, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.